KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio: 2009-2018

Historic FCF Payout Ratio for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Mar 2018 value amounting to 0.01.

  • Teva Pharmaceutical Industries' FCF Payout Ratio rose 100.17% to 0.01 in Q1 2018 from the same period last year, while for Mar 2018 it was 0.21, marking a year-over-year decrease of 56.45%. This contributed to the annual value of 0.23 for FY2019, which is 3388.04% up from last year.
  • According to the latest figures from Q1 2018, Teva Pharmaceutical Industries' FCF Payout Ratio is 0.01, which was down 93.87% from 0.15 recorded in Q4 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' FCF Payout Ratio registered a high of 10.52 during Q4 2014, and its lowest value of -5.24 during Q1 2017.
  • Moreover, its 2-year median value for FCF Payout Ratio was 0.15 (2017), whereas its average is -0.69.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' FCF Payout Ratio skyrocketed by 615.27% in 2014 and then plummeted by 39.78% in 2015.
  • Quarterly analysis of 4 years shows Teva Pharmaceutical Industries' FCF Payout Ratio stood at 10.52 in 2014, then tumbled by 39.78% to 6.33 in 2015, then reached 0.15 in 2017, then soared by 100.17% to 0.01 in 2018.
  • Its last three reported values are 0.01 in Q1 2018, 0.15 for Q4 2017, and 0.21 during Q3 2017.